Artículos por temáticas

[Cataract surgery among 50 Alzheimer's patient (55 eyes)]

Girard B, Chouard B, Hardy F.

J Fr Ophtalmol. 2017 Jun;40(6):487-498. doi: 10.1016/j.jfo.2017.01.006. Epub 2017 May 29.

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients

Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM.

J Alzheimers Dis. 2017;57(2):557-573. doi: 10.3233/JAD-160216.

[Changes in drug management of Alzheimer's disease in nursing homes: Impact of the media campaign against specific drugs for Alzheimer's disease]

Petit AE, Mangeard H, Chazard E, Puisieux F.

Encephale. 2017 Feb;43(1):21-26. doi: 10.1016/j.encep.2015.03.006. Epub 2016 Mar 30.

Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index

Lee C, Lee K, Yu H, Ryu SH, Moon SW, Han C, Lee JY, Lee YM, Kim SG, Kim KW, Lee DW, Kim SY, Lee SY, Bae JN, Jung YE, Kim JL, Kim BS, Shin IS, Kim YH, Kim BJ, Kang HS, Myung W, Carroll BJ, Kim DK.

J Clin Psychopharmacol. 2017 Aug;37(4):401-404. doi: 10.1097/JCP.0000000000000726.

A benzothiazole/piperazine derivative with acetylcholinesterase inhibitory activity: Improvement in streptozotocin-induced cognitive deficits in rats

Demir Özkay Ü, Can ÖD, Sağlık BN, Turan N.

Pharmacol Rep. 2017 Dec;69(6):1349-1356. doi: 10.1016/j.pharep.2017.06.009. Epub 2017 Jun 30.

Yoga and compassion meditation program improve quality of life and self-compassion in family caregivers of Alzheimer's disease patients: A randomized controlled trial

Danucalov MA, Kozasa EH, Afonso RF, Galduroz JC, Leite JR.

Geriatr Gerontol Int. 2017 Jan;17(1):85-91. doi: 10.1111/ggi.12675. Epub 2015 Dec 21.

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease

Cavedo E, Grothe MJ, Colliot O, Lista S, Chupin M, Dormont D, Houot M, Lehéricy S, Teipel S, Dubois B, Hampel H; Hippocampus Study Group.

Sci Rep. 2017 Sep 15;7(1):11706. doi: 10.1038/s41598-017-09780-3.

Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease

Bando N, Nakamura Y.

Geriatr Gerontol Int. 2017 Sep;17(9):1306-1312. doi: 10.1111/ggi.12865. Epub 2016 Aug 21.

Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials

Fleisher AS, Joshi AD, Sundell KL, Chen YF, Kollack-Walker S, Lu M, Chen S, Devous MD Sr, Seibyl J, Marek K, Siemers ER, Mintun MA.

Alzheimers Dement. 2017 Oct;13(10):1117-1124. doi: 10.1016/j.jalz.2017.02.009. Epub 2017 Mar 30.

Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial

Park KW, Kim EJ, Han HJ, Shim YS, Kwon JC, Ku BD, Park KH, Yi HA, Kim KK, Yang DW, Lee HW, Kang H, Kwon OD, Kim S, Lee JH, Chung EJ, Park SW, Park MY, Yoon B, Kim BC, Seo SW, Choi SH.

PLoS One. 2017 Aug 7;12(8):e0182123. doi: 10.1371/journal.pone.0182123. eCollection 2017.

The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial

Rijpma A, van der Graaf M, Lansbergen MM, Meulenbroek O, Cetinyurek-Yavuz A, Sijben JW, Heerschap A, Olde Rikkert MGM.

Alzheimers Res Ther. 2017 Jul 26;9(1):51. doi: 10.1186/s13195-017-0286-2.

Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)

Yoon SJ, Choi SH, Na HR, Park KW, Kim EJ, Han HJ, Lee JH, Shim YS, Na DL.

Geriatr Gerontol Int. 2017 Mar;17(3):494-499. doi: 10.1111/ggi.12754. Epub 2016 Apr 25.

Effect of different blood glucose intervention plans on elderly people with type 2 diabetes mellitus combined with dementia

Chen Y, Wang J, Wang LJ, Lin H, Huang PJ.

Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2702-2707.

Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels

Youn K, Yu Y, Lee J, Jeong WS, Ho CT, Jun M.

Nutrients. 2017 Sep 4;9(9):973. doi: 10.3390/nu9090973.

MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease

Regan B, Wells Y, Farrow M, O'Halloran P, Workman B.

Am J Geriatr Psychiatry. 2017 Mar;25(3):258-269. doi: 10.1016/j.jagp.2016.11.008. Epub 2016 Nov 16.